A phase III randomized trial of adjuvant therapy with irsogladine maleate for the patient with completely resected non-small cell lung cancer
Phase 3
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000005901
- Lead Sponsor
- Japanese Northern East Area Thoracic Surgery Study Group (JNETS)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 310
Inclusion Criteria
Not provided
Exclusion Criteria
multiple cancer within 5 years sever organ failure past history of radiotherapy/chemotherapy women with pregnancy or breast feeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall survival
- Secondary Outcome Measures
Name Time Method relapse-free survival